﻿<?xml version="1.0" encoding="utf-8"?>
<Return returnVersion="2015v3.0" xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2017-02-14T17:48:09-08:00</ReturnTs>
    <TaxPeriodEndDt>2016-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>461290911</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>PATRICIA PICH CPA</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>300 DESCHUTES WAY SW STE 312</AddressLine1Txt>
        <CityNm>TUMWATER</CityNm>
        <StateAbbreviationCd>WA</StateAbbreviationCd>
        <ZIPCd>985017719</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2015-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>911435394</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>POINT DEFIANCE AIDS PROJECTS</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>POIN</BusinessNameControlTxt>
      <PhoneNum>2532724857</PhoneNum>
      <USAddress>
        <AddressLine1Txt>535 DOCK STREET STE 113</AddressLine1Txt>
        <CityNm>TACOMA</CityNm>
        <StateAbbreviationCd>WA</StateAbbreviationCd>
        <ZIPCd>984024629</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JANE HALLSTROM</PersonNm>
      <PersonTitleTxt>TREASURER</PersonTitleTxt>
      <PhoneNum>2532724857</PhoneNum>
      <SignatureDt>2017-01-25</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>PATRICIA PICH</PreparerPersonNm>
      <PTIN>P01558603</PTIN>
      <PhoneNum>3603397867</PhoneNum>
      <PreparationDt>2017-01-31</PreparationDt>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2015</TaxYr>
    <BuildTS>2021-01-29 14:40:06Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="6">
    <IRS990 documentId="RetDoc3" referenceDocumentId="RetDoc6">
      <PrincipalOfficerNm>DALE CHRISTENSEN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>535 DOCK ST</AddressLine1Txt>
        <AddressLine2Txt>STE 113</AddressLine2Txt>
        <CityNm>TACOMA</CityNm>
        <StateAbbreviationCd>WA</StateAbbreviationCd>
        <ZIPCd>98402</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>1730115</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.NASEN.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1988</FormationYr>
      <LegalDomicileStateCd>WA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>AGENCY HISTORY: POINT DEFIANCE AIDS PROJECTS (PDAP) WAS INCORPORATED AS A 501C (3) NONPROFIT AGENCY ON DECEMBER 5, 1988. PDAP'S FOUNDER, DAVE PURCHASE, WITNESSED MANY OF THE PEOPLE FOR WHOM HE PROVIDED CHEMICAL DEPENDENCY COUNSELING DIE OF A DISEASE THAT WOULD LATER COME TO BE KNOWN AS AIDS. THIS EXPERIENCE SHIFTED HIS FOCUS FROM CHEMICAL DEPENDENCY TREATMENT TO PREVENTING THE SPREAD OF HIV. DAVE PUT IT THIS WAY, "DEAD PEOPLE CAN'T TWO-STEP LET ALONE 12-STEP." HE KNEW OF INTERNATIONAL PROGRAMS THAT PROVIDED DRUG USERS WITH CLEAN SYRINGES IN AN EFFORT TO REDUCE NEEDLE SHARING. THEIR SUCCESS IN STEMMING THE SPREAD OF DISEASE COMPELLED DAVE AND OTHERS TO FOUND THE TACOMA NEEDLE EXCHANGE PROGRAM (TNEP). TNEP IS THE FIRST LEGALLY SANCTIONED SYRINGE SERVICE PROGRAM (SSP) IN THE U.S. AND HAS OPERATED CONTINUOUSLY SINCE 1988. AS INTEREST IN THE PUBLIC HEALTH APPLICATION OF SYRINGE EXCHANGE SPREAD, TNEP AND OTHER EMERGING SSPS WERE OVERWHELMED WITH TECHNICAL ASSISTANCE AND INFORMATION REQUESTS.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>10</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>10</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>17</TotalEmployeeCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>653680</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1514759</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>3367</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>2000</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>1345</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>99442</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>119368</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>758489</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>1635472</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>388513</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>505333</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>348428</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>995940</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>736941</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1501273</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>21548</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>134199</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>1295417</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>2505493</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>1059917</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>2135794</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>235500</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>369699</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>MISSION: POINT DEFIANCE AIDS PROJECTS REDUCES THE SPREAD OF BLOOD BORNE DISEASES.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>872400</ExpenseAmt>
      <Desc>NETWORK OF ORGANIZATIONS AND INDIVIDUALS THAT ADVOCATE FOR SYRINGE EXCHANGE. NASEN'S SERVICES INCLUDE THE BUYERS' CLUB; U.S. SYRINGE EXCHANGE DIRECTORY; START-UP KITS &amp; FISCAL SPONSORSHIP NASEN'S MISSION IS TO SUPPORT SYRINGE EXCHANGE PROGRAMS AND TO ENCOURAGE THE EXPANSION OF A FOR SMALL AND EMERGING SEPS; LOAN ASSISTANCE; DAVE PURCHASE MEMORIAL SYRINGE EXCHANGE SURVEY BUYERS' CLUB (BC): THE BUYERS' CLUB IS A PURCHASING NETWORK THAT USES CO-OPERATIVE BUYING POWER TO ACQUIRE THE LOWEST SYRINGE PRICES FOR SEPS. IN 2016, THE BC PURCHASED MORE THAN 6,600,000 IN SUPPLIES ON BEHALF OF 285 SEPS. IT IS ESTIMATED THE BC SAVES THE FIELD OF SEPS 2,000,000 ANNUALLY. START-UP KITS: NASEN IS ONE OF THE ONLY SOURCES OF SYRINGE EXCHANGE START-UP ASSISTANCE FOR NEW PROGRAMS WITH LITTLE OR NO OPERATIONAL HISTORY. FINANCIAL AND TECHNICAL HELP ARE PROVIDED TO GRASS ROOTS PROGRAMS IN AREAS OF THE COUNTRY WITH LIMITED RESOURCES. U.S. SYRINGE EXCHANGE DIRECTORY: THE PRUPOSE OF NASEN'S U.S. SYRINGE EXCHANGE DIRECTORY IS TO FACILITATE COMMUNICATION AND NETWORKING AMONG SEPS. MANY PROGRAMS OPERATE UNDER CONDITIONS THAT DO NOT ALLOW THEM TO PUBLISH THEIR INFORMATION. NASEN ACTS AS A GATEKEEPER, ENSURING DATA CAN BE COLLECTED FROM THE SEPS AND GENERAL INFORMATION CAN BE DISSEMINATED TO THEM WHILE KEEPING THE PROGRAM'S INFORMATION CONFIDENTIAL. FISCAL SPONSORSHIP: MANY SMALL AND EMERGING SEPS HAVE NOT RECEIVED 501 (C)(3) DESIGNATION. NASEN CAN ACT AS FISCAL SPONSOR TO ASSIST THESE PROGRAMS AS THEY APPLY FOR FUNDING AND SOLICIT DONATIONS. LOAN ASSISTANCE: OCCASIONALLY, SEPS CANNOT COVER OPERATING EXPENSES FOR A PERIOD OF TIME. THIS GENERALLY OCCURS WHEN A GRANT HAS BEEN AWARDED BUT RECEIPT OF FUNDING IS DELAYED. NASEN PROVIDES SHORT TERM ASSISTANCE IN THE FORM OF A LOAN OR CREDIT WITH THE BUYERS CLUB SO THE PROGRAM IS NOT FORCED TO CURTAIL OR CEASE OPERATIONS. DAVE PURCHASE MEMORIAL SYRINGE EXCHANGE SURVEY. NASEN COLLABORATES ANNUALLY WITH THE BETH ISRAEL MEDICAL CENTER (BIMC) TO CONDUCT THE MOST COMPREHENSIVE SURVEY OF SEPS. SINCE 1994, SURVEY RESULTS HAVE PROVIDED THE ONLY SOURCE OF CURRENT DATA ON SEP OPERATIONS IN THE U.S. THIS INFORMATION IS VITAL TO SYRINGE EXCHANGE RELATED POLICY WORK, INCLUDING EFFORTS TO REVERSE THE FEDERAL BAN ON FUNDING FOR SYRINGE EXCHANGE, AND MUST BE AVAILABLE TO POLICY MAKERS, RESOUCE ALLOCATORS, AND SYRINGE EXCHANGE PROVIDERS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>610084</ExpenseAmt>
        <Desc>DRUG USER HEALTH FOR 28 YEARS, THE TACOMA NEEDLE EXCHANGE HAS WORKED TO IMPROVE THE HEALTH OF PIERCE COUNTY'S DRUG INJECTORS AND SEX WORKERS, MANY OF WHOM ARE VERY LOW INCOME OR CHRONICALLY HOMELESS. "TNE PROMOTES AWARENESS OF SAFER INJECTION AND SEXUAL PRACTICES, AND DISTRIBUTES STERILE INJECTING EQUIPMENT AND SAFER SEX MATERIALS. THIS EFFORT REDUCES DISEASE TRANSMISSION, INJECTION RELATED WOUNDS, SKIN AND SOFT TISSUE INFECTIONS, AND AMPUTATIONS. SYRINGE EXCHANGE SAVES LIVES AND REDUCES MEDICAL COSTS ASSOCIATED WITH THESE PREVENTABLE CONDITIONS. "TNE DISTRIBUTES SPECIALLY DESIGNED WOUND CARE KITS FOR THE TREATMENT AND CONTAINMENT OF COMMUNITY ACQUIRED MRSA. "TNE EXCHANGES NEARLY 2 MILLION SYRINGES ANNUALLY. REMOVING THIS VOLUME OF SYRINGES FROM THE WASTE STREAM IMPROVES THE SAFETY OF THE GENERAL PUBLIC, SANITATION WORKERS, POLICE AND FIRE FIGHTERS. "TNE PARTNERS WITH THE CITY OF TACOMA, TACOMA POLICE DEPARTMENT, LOCAL BUSINESSES, AND OTHERS TO ENSURE PROPER CLEAN-UP OF USED SYRINGES DISCARDED IN PUBLIC SPACES. "TNE'S COMMUNITY HEALTH WORKERS PROVIDE PERSONAL SUPPORT FOR VULNERABLE INDIVIDUALS, REFERRALS TO TREATMENT FOR SUBSTANCE USE DISORDERS AND MENTAL ILLNESS, ACCESS TO HEALTH AND SOCIAL SERVICES, TESTING AND COUNSELING FOR HIV/HCV/SYPHILIS, AND ASSISTANCE WITH HEALTH INSURANCE ENROLLMENT "TNE'S CARE COORDINATORS TRANSPORT AND ACCOMPANY PARTICIPANTS TO HEALTH APPOINTMENTS, ASSIST WITH ACQUIRING AND MAINTAINING HOUSING, PROMOTE MEDICATION MANAGEMENT AND TREATMENT ADHERENCE. THESE EVIDENCE-BASED INTERVENTIONS INCREASE ACCESS TO THE TOOLS, INFORMATION, AND RESOURCES PEOPLE NEED TO CARE FOR THEMSELVES. THEY ALSO IMPROVE HEALTH AND REDUCE COSTS IN THE PROCESS.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>18789</ExpenseAmt>
        <Desc>OTHER PROGRAM COORDINATING BULK BUYING FOR 176 NEEDLE EXCHANGE PROGRAMS AROUND THE COUNTRY.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>1501273</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc7">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc4">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc4">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc4">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc4">false</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc4">false</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc4">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc4">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc4">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc4">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc4">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc4">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc4">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc4">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>false</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="RetDoc5">true</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="RetDoc5">false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>1</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>17</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>10</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>10</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>ALISA SOLBERG</PersonNm>
        <PhoneNum>2532724857</PhoneNum>
        <USAddress>
          <AddressLine1Txt>535 DOCK ST 113</AddressLine1Txt>
          <CityNm>TACOMA</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>98402</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHAEL CARROLL</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JANE HALLSTROM</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DOUG TUFTS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>FEDERICO CRUZ-URIBE</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAN KREBS</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HEIDI SMIDT</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DALE CHRISTENSEN</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAUL LAKOSKY</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LORI LINENBERGER</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA MILLER</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALISA SOLBERG</PersonNm>
        <TitleTxt>EXECUTIVE DI</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>62216</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>62216</TotalReportableCompFromOrgAmt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <GovernmentGrantsAmt>1277797</GovernmentGrantsAmt>
      <AllOtherContributionsAmt>236962</AllOtherContributionsAmt>
      <NoncashContributionsAmt>233105</NoncashContributionsAmt>
      <TotalContributionsAmt>1514759</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>1345</TotalRevenueColumnAmt>
        <ExclusionAmt>1345</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossSalesOfInventoryAmt>160819</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>94643</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>66176</TotalRevenueColumnAmt>
        <ExclusionAmt>66176</ExclusionAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>REBATE/POINT INCOME</Desc>
        <TotalRevenueColumnAmt>48712</TotalRevenueColumnAmt>
        <ExclusionAmt>48712</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>OTHER INCOME</Desc>
        <TotalRevenueColumnAmt>4480</TotalRevenueColumnAmt>
        <ExclusionAmt>4480</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>53192</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>1635472</TotalRevenueColumnAmt>
        <ExclusionAmt>120713</ExclusionAmt>
      </TotalRevenueGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>427325</TotalAmt>
        <ProgramServicesAmt>365970</ProgramServicesAmt>
        <ManagementAndGeneralAmt>61355</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>33184</TotalAmt>
        <ProgramServicesAmt>29052</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4132</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>44824</TotalAmt>
        <ProgramServicesAmt>34631</ProgramServicesAmt>
        <ManagementAndGeneralAmt>10193</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>74565</TotalAmt>
        <ProgramServicesAmt>70950</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3615</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>581140</TotalAmt>
        <ProgramServicesAmt>567468</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13672</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <OccupancyGrp>
        <TotalAmt>38645</TotalAmt>
        <ProgramServicesAmt>37535</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1110</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>10299</TotalAmt>
        <ProgramServicesAmt>8930</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1369</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>261890</TotalAmt>
        <ProgramServicesAmt>256787</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5103</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>5302</TotalAmt>
        <ProgramServicesAmt>5302</ProgramServicesAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>19818</TotalAmt>
        <ProgramServicesAmt>7428</ProgramServicesAmt>
        <ManagementAndGeneralAmt>12390</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>OTHER</Desc>
        <TotalAmt>7117</TotalAmt>
        <ProgramServicesAmt>7085</ProgramServicesAmt>
        <ManagementAndGeneralAmt>32</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>ADMINISTRATIVE ALLOCATION</Desc>
        <TotalAmt>-2836</TotalAmt>
        <ProgramServicesAmt>110135</ProgramServicesAmt>
        <ManagementAndGeneralAmt>-112971</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1501273</TotalAmt>
        <ProgramServicesAmt>1501273</ProgramServicesAmt>
        <ManagementAndGeneralAmt>0</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>766914</BOYAmt>
        <EOYAmt>563078</EOYAmt>
      </CashNonInterestBearingGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>111123</BOYAmt>
        <EOYAmt>731337</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>384499</BOYAmt>
        <EOYAmt>1153339</EOYAmt>
      </AccountsReceivableGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>13919</BOYAmt>
        <EOYAmt>21254</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>7403</BOYAmt>
        <EOYAmt>11150</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>66430</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>41095</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>11559</BOYAmt>
        <EOYAmt>25335</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <TotalAssetsGrp>
        <BOYAmt>1295417</BOYAmt>
        <EOYAmt>2505493</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>900495</BOYAmt>
        <EOYAmt>1881859</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>159422</BOYAmt>
        <EOYAmt>253935</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>1059917</BOYAmt>
        <EOYAmt>2135794</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>235500</BOYAmt>
        <EOYAmt>369699</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>235500</BOYAmt>
        <EOYAmt>369699</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>1295417</BOYAmt>
        <EOYAmt>2505493</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>134199</ReconcilationRevenueExpnssAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc7">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>619730</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>510360</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>522801</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>653680</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1514759</CurrentTaxYearAmt>
        <TotalAmt>3821330</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>619730</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>510360</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>522801</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>653680</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1514759</CurrentTaxYearAmt>
        <TotalAmt>3821330</TotalAmt>
      </TotalCalendarYear170Grp>
      <PublicSupportTotal170Amt>3821330</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>20</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1156</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1760</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2000</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1345</CurrentTaxYearAmt>
        <TotalAmt>6281</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>13965</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>6609</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>137851</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>222501</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>214011</CurrentTaxYearAmt>
        <TotalAmt>594937</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>4422548</TotalSupportAmt>
      <PublicSupportCY170Pct>0.86410</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.87430</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>PART II, LINE 10</FormAndLineReferenceDesc>
        <ExplanationTxt>380,926</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SUPPLEMENTAL INFORMATION</FormAndLineReferenceDesc>
        <ExplanationTxt>THE 5 YEAR AMOUNT FOR OTHER REVENUE WHICH CONSISTS OF NET SALES FOR COTTON AND COOKERS AS PART OF THE DISEASE PREVENTION MISSION OF PDAP.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc4">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>2000</OtherCostOrOtherBasisAmt>
        <BookValueAmt>2000</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>64430</OtherCostOrOtherBasisAmt>
        <BookValueAmt>64430</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>66430</TotalBookValueLandBuildingsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>TRUST FUNDS PAYABLE</Desc>
        <Amt>253935</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>253935</TotalLiabilityAmt>
      <TotalRevEtcAuditedFinclStmtAmt>1635472</TotalRevEtcAuditedFinclStmtAmt>
      <RevenueSubtotalAmt>1635472</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>1635472</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>1501273</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>1501273</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>1501273</TotalExpensesPerForm990Amt>
    </IRS990ScheduleD>
    <IRS990ScheduleM documentId="RetDoc5">
      <DrugsAndMedicalSuppliesGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>1</ContributionCnt>
        <NoncashContributionsRptF990Amt>233105</NoncashContributionsRptF990Amt>
      </DrugsAndMedicalSuppliesGrp>
      <AnyPropertyThatMustBeHeldInd>false</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>false</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>false</ThirdPartiesUsedInd>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="RetDoc6">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>START-UP KITS: NASEN IS ONE OF THE ONLY SOURCES OF SYRINGE EXCHANGE START-UP ASSISTANCE FOR NEW PROGRAMS WITH LITTLE OR NO OPERATIONAL HISTORY. FINANCIAL AND TECHNICAL HELP ARE PROVIDED TO GRASS ROOTS PROGRAMS IN AREAS OF THE COUNTRY WITH LIMITED RESOURCES. U.S. SYRINGE EXCHANGE DIRECTORY: THE PRUPOSE OF NASEN'S U.S. SYRINGE EXCHANGE DIRECTORY IS TO FACILITATE COMMUNICATION AND NETWORKING AMONG SEPS. MANY PROGRAMS OPERATE UNDER CONDITIONS THAT DO NOT ALLOW THEM TO PUBLISH THEIR INFORMATION. NASEN ACTS AS A GATEKEEPER, ENSURING DATA CAN BE COLLECTED FROM THE SEPS AND GENERAL INFORMATION CAN BE DISSEMINATED TO THEM WHILE KEEPING THE PROGRAM'S INFORMATION CONFIDENTIAL. FISCAL SPONSORSHIP: MANY SMALL AND EMERGING SEPS HAVE NOT RECEIVED 501 (C)(3) DESIGNATION. NASEN CAN ACT AS FISCAL SPONSOR TO ASSIST THESE PROGRAMS AS THEY APPLY FOR FUNDING AND SOLICIT DONATIONS. LOAN ASSISTANCE: OCCASIONALLY, SEPS CANNOT COVER OPERATING EXPENSES FOR A PERIOD OF TIME. THIS GENERALLY OCCURS WHEN A GRANT HAS BEEN AWARDED BUT RECEIPT OF FUNDING IS DELAYED. NASEN PROVIDES SHORT TERM ASSISTANCE IN THE FORM OF A LOAN OR CREDIT WITH THE BUYERS CLUB SO THE PROGRAM IS NOT FORCED TO CURTAIL OR CEASE OPERATIONS. DAVE PURCHASE MEMORIAL SYRINGE EXCHANGE SURVEY. NASEN COLLABORATES ANNUALLY WITH THE BETH ISRAEL MEDICAL CENTER (BIMC) TO CONDUCT THE MOST COMPREHENSIVE SURVEY OF SEPS. SINCE 1994, SURVEY RESULTS HAVE PROVIDED THE ONLY SOURCE OF CURRENT DATA ON SEP OPERATIONS IN THE U.S. THIS INFORMATION IS VITAL TO SYRINGE EXCHANGE RELATED POLICY WORK, INCLUDING EFFORTS TO REVERSE THE FEDERAL BAN ON FUNDING FOR SYRINGE EXCHANGE, AND MUST BE AVAILABLE TO POLICY MAKERS, RESOUCE ALLOCATORS, AND SYRINGE EXCHANGE PROVIDERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>"TNE DISTRIBUTES SPECIALLY DESIGNED WOUND CARE KITS FOR THE TREATMENT AND CONTAINMENT OF COMMUNITY ACQUIRED MRSA. "TNE EXCHANGES NEARLY 2 MILLION SYRINGES ANNUALLY. REMOVING THIS VOLUME OF SYRINGES FROM THE WASTE STREAM IMPROVES THE SAFETY OF THE GENERAL PUBLIC, SANITATION WORKERS, POLICE AND FIRE FIGHTERS. "TNE PARTNERS WITH THE CITY OF TACOMA, TACOMA POLICE DEPARTMENT, LOCAL BUSINESSES, AND OTHERS TO ENSURE PROPER CLEAN-UP OF USED SYRINGES DISCARDED IN PUBLIC SPACES. "TNE'S COMMUNITY HEALTH WORKERS PROVIDE PERSONAL SUPPORT FOR VULNERABLE INDIVIDUALS, REFERRALS TO TREATMENT FOR SUBSTANCE USE DISORDERS AND MENTAL ILLNESS, ACCESS TO HEALTH AND SOCIAL SERVICES, TESTING AND COUNSELING FOR HIV/HCV/SYPHILIS, AND ASSISTANCE WITH HEALTH INSURANCE ENROLLMENT "TNE'S CARE COORDINATORS TRANSPORT AND ACCOMPANY PARTICIPANTS TO HEALTH APPOINTMENTS, ASSIST WITH ACQUIRING AND MAINTAINING HOUSING, PROMOTE MEDICATION MANAGEMENT AND TREATMENT ADHERENCE. THESE EVIDENCE-BASED INTERVENTIONS INCREASE ACCESS TO THE TOOLS, INFORMATION, AND RESOURCES PEOPLE NEED TO CARE FOR THEMSELVES. THEY ALSO IMPROVE HEALTH AND REDUCE COSTS IN THE PROCESS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FORM 990 IS PRESENTED, FOR A DETAILED REVIEW, TO THE BOARD PRIOR TO THEIR DISCUSSION/VOTE FOR APPROVAL TO BE FILED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE EXECUTIVE DIRECTOR IS EVALUATED ANNUALLY BY THE BOARD OF DIRECTORS, WHO THEN SET COMPENSATION BASED ON THE EVALUATION. THE PROCESS IS DOCUMENTED IN THE MINUTES OF THE BOARD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>GOVERNING DOCUMENTS AND TAX RETURN ARE AVAILABLE UPON REQUEST BY CALLING THE OFFICE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>